FDA Clears Restylane Contour for Temple Hollowing
The expanded indication is based on clinical data showing high responder rates and results lasting up to 18 months, with no serious adverse events reported.
The expanded indication is based on clinical data showing high responder rates and results lasting up to 18 months, with no serious adverse events reported.
The Women and Equalities Committee's report highlights patient safety failures tied to unregulated surgical and non-surgical cosmetic procedures, including gaps in data collection, informed consent, and clinical oversight.
Phase 4 study data presented at the American Academy of Pain Medicine PainConnect 2026 meeting reported that more than 90% of patients undergoing aesthetic or reconstructive procedures remained opioid-free when treated with Journavx as part of multimodal pain therapy.
Findings provide insight into the biological mechanisms of picosecond lasers for pigmentation disorders and skin aging, potentially enabling safer parameter selection and clinical application.
Plastic surgeons are calling for a ban on dermal fillers being injected into breasts, warning the procedure carries "unacceptable" risks.